Quick comparison: Foundayo vs the Wegovy pill
Foundayo and the Wegovy pill are both once-daily oral GLP-1 medicines for weight loss, and both are available in the UAE in 2026. The biggest practical difference is how you take them. Foundayo can be taken at any time of day, with or without food. The Wegovy pill is taken in the morning on an empty stomach, with a short wait before eating. In clinical trials, average weight loss was about 17% of total body weight with the Wegovy pill (oral semaglutide 25 mg) and about 12% with Foundayo. Both are effective options, and the right one for you is a clinical decision made with your specialist.
How each pill works
Both medicines are GLP-1 receptor agonists. They act on appetite signals so you feel full sooner and eat less, the same mechanism as the injectable GLP-1 treatments many patients already know. Our guide to the oral GLP-1 pill versus the injection compares the two routes in detail. The difference between the two pills is the molecule and how it is taken.
Foundayo (orforglipron)
Foundayo is orforglipron, made by Eli Lilly. It is a small-molecule GLP-1 tablet, and its standout feature is flexibility: it can be taken any time of day, with or without food. You can read more on our Foundayo page.
The Wegovy pill (oral semaglutide 25 mg)
The Wegovy pill is oral semaglutide, semaglutide in tablet form, made by Novo Nordisk, taken at the 25 mg weight-loss dose. It is the oral version of the same molecule used in the Wegovy injection.
Dosing and food rules: the biggest practical difference
For day-to-day life, this is where the two pills differ most.
Foundayo is forgiving. One tablet a day, at a time that suits you, with or without food, and no waiting period. That makes it easy to fit around shift work, travel, or an unpredictable routine.
The Wegovy pill is more structured. It is taken in the morning on an empty stomach, with a small sip of water, and you wait about 30 minutes before eating, drinking, or taking other medicines. The routine is manageable, but it asks for more consistency.
Both pills start at a low strength and step up gradually. Your specialist decides the timing of each increase based on how you respond and tolerate the medicine, so the path to an effective dose is personalised rather than fixed.
Average weight loss: what the trials show
It helps to look at the trial figures side by side, while remembering these are averages from different studies.
In the OASIS-4 trial, the Wegovy pill (oral semaglutide 25 mg) produced about 17% average weight loss over 64 weeks, and about one in three people lost 20% or more, results broadly similar to the 2.4 mg Wegovy injection. In the ATTAIN-1 trial, Foundayo produced about 12% average weight loss, with some patients losing up to 15%.
On the headline number, the Wegovy pill is higher. That does not make Foundayo a weak choice. It is an effective pill with a real convenience advantage, and for many patients the easier routine matters. It is also worth keeping perspective on the wider landscape: leading injections still lead on magnitude, with Mounjaro averaging around 20% at its top dose in the SURMOUNT-1 trial. The pills and the injections each have a place.
A note on manufacturer claims: Novo Nordisk materials make direct head-to-head claims that the Wegovy pill is more effective than Foundayo (orforglipron), based on an indirect comparison published in 2026. Where that comparison is cited, it did show higher average weight loss for oral semaglutide. We mention it here as the manufacturer’s claim and the source it rests on, not as a verdict on which pill is right for you.
Side effects and tolerability
Both pills can bring similar side effects, because they belong to the same class. The most common are gastrointestinal: nausea, a feeling of fullness, mild reflux, or changes in bowel habit. These are reported more often around the time the dose goes up, can be particularly noticeable in the first few days at a new step, and usually settle within the first two weeks. Not every patient experiences them. Starting low and stepping up slowly is the main way both medicines keep these symptoms manageable.
Where injections still fit, and other oral options
Pills are not the only route, and they are not automatically the best route for everyone. If you want the full picture on tablets versus needles, our guide to the weight loss pill versus injection in the UAE covers it in detail. Among oral options, Foundayo and the Wegovy pill are the two newest weight-loss pills, while Qsymia and Rybelsus remain established choices for their own specific situations. Which route and which medicine suit you depends on your goals, your medical history, and your preferences.
Who each pill may suit
Rather than ranking them, it helps to think about fit.
Foundayo may suit people who value flexibility: irregular schedules, frequent travel, or a strong dislike of fixed routines and fasting windows. The any-time, with-or-without-food rule is a genuine advantage for daily life.
The Wegovy pill may suit people who are comfortable with a morning, empty-stomach routine and who want the higher average result seen in its trial. Some patients also like that it is the same molecule as the familiar Wegovy injection.
These are general patterns, not rules. The only way to know which is right for you is a proper assessment.
How a specialist chooses between them
In practice, the choice is rarely about a single number. Your specialist weighs your weight-loss goal, your medical history and any other conditions, your tolerance for side effects, your daily routine, and your own preference between the two pills. All of these medicines have subtle differences that are best discussed with a doctor before deciding. That is why both pills at Endocare are prescribed through a GLP-1 weight loss consultation, with body-composition tracking and lifestyle coaching alongside, so the plan fits the person, not just the average.
Frequently asked questions
Which is better, Foundayo or the Wegovy pill?
Neither is simply better. The Wegovy pill has a higher average result in its trial, while Foundayo is more flexible to take. The right choice depends on your goals, routine, and clinical assessment with your specialist.
Is the Wegovy pill stronger than Foundayo?
On average trial results, the Wegovy pill reached about 17% of body weight and Foundayo about 12%. Both are effective oral GLP-1 medicines, and the higher average does not automatically make it the right pill for you.
What is the main difference in how I take them?
Foundayo can be taken any time of day, with or without food. The Wegovy pill is taken in the morning on an empty stomach, with about a 30-minute wait before food or other medicines.
Can I switch from one pill to the other?
Sometimes, but this is a clinical decision. If one pill does not suit you on tolerability or routine, your specialist can review whether switching makes sense for you.
Are both pills available in the UAE?
Yes. Both Foundayo and the Wegovy pill are available in the UAE in 2026 and are prescribed at Endocare in Dubai and Abu Dhabi under specialist supervision.
Do injections still work better?
Leading injections such as Mounjaro still produce the highest average weight loss, around 20% at the top dose. The pills are effective alternatives, especially for patients who prefer tablets over needles.
Talk to an endocrinologist about your options
Choosing between two good options is easier with expert input. Book a consultation with an Endocare endocrinologist in Dubai or Abu Dhabi, and we will help you weigh Foundayo and the Wegovy pill against your goals and build a personalised plan. You can also call the clinic or message us on WhatsApp.
